e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 41

LAG-3 expression in the inflammatory microenvironment of glioma

Maximilian J. Mair; Barbara Kiesel; Katharina Feldmann; Georg Widhalm; Karin Dieckmann; Adelheid Wöhrer; Leonhard Müllauer; Matthias Preusser · 2021 · Journal of Neuro-Oncology

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

PURPOSE: Immune modulatory therapies including immune checkpoint inhibitors have so far failed to result in clinically meaningful efficacy in glioma. We aimed to investigate lymphocyte activation gene 3 (LAG-3), an inhibitory receptor on immune cells and target of second-generation immune checkpoint inhibitors, in glioma. METHODS: 97 patients with diffuse glioma (68 with glioblastoma, 29 with WHO grade II-III glioma) were identified from the Neuro-Biobank of the Medical University of Vienna. LAG-3 expression in the inflammatory microenvironment was assessed by immunohistochemistry (monoclonal

Abstract by Maximilian J. Mair; Barbara Kiesel; Katharina Feldmann; Georg Widhalm; Karin Dieckmann; Adelheid Wöhrer; Leonhard Müllauer; Matthias Preusser, Journal of Neuro-Oncology (2021) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1007/s11060-021-03721-x